News Article

International medical diagnostic and laboratory services provider Synlab is to divest its entire Finnish network of diagnostics, sample-collection and imaging clinics to PlusTerveys, Finland’s largest dental care chain.

The private market transaction has just received unconditional clearance from the Finnish Competition and Consumer Authority. The deal covers thirty-eight physical clinics and imaging locations distributed across Finland, with completion expected around the end of the year.

As part of the transaction structure, Synlab Finland will retain its centralised laboratory and analysis business, ensuring it continues to provide advanced clinical analysis services to the divested locations under a separate, long-term service agreement.

For PlusTerveys this acquisition marks a major strategic expansion to diversify beyond dental and mental health services into a nationwide diagnostics and primary care support network, highlighting the ongoing consolidation within the European laboratory and diagnostic services sector as operators seek to optimise their physical clinic footprints while retaining high-margin centralised testing processing.

Synlab was previously a publicly listed company on the Frankfurt Stock Exchange, delisting in 2024 following a buyout from private equity firm Cinven.